Previous Article | Next Article ![]()
Journal of Bacteriology, October 2004, p. 6706-6713, Vol. 186, No. 20
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.20.6706-6713.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
and Guangyong Ji*
Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Received 12 March 2004/ Accepted 15 July 2004
|
|
|---|
-helix and the extracellular loop 1 of group I AgrB were decisive in the specific processing of group I AgrD. In contrast, two hydrophilic segments of group II AgrB played a crucial role in the group-specific processing of group II AgrD. We also found that several chimeric AgrBs were capable of processing AgrD from both groups, suggesting that all AgrB homologues may utilize the same or a similar mechanism in the processing of AgrDs. |
|
|---|
The interaction between the mature AIP and AgrC is group specific (3, 6). Based on the agr sequences and the specific recognition between the AIP and AgrC, four groups of S. aureus have been identified so far (2, 3, 9). The mature AIP activates the agr responses in strains that belong to the same group, while it inhibits those in strains from heterologous groups (2, 3, 7-9). However, conflicting results have been reported on the activities of group IV AIP. Lyon et al. (7) showed that synthetic group I AIP could weakly activate the agr response in group IV strain and group IV AIP could strongly activate that in group I strains. In contrast, McDowell et al. (9) reported that synthetic group IV AIP activated the agr response in group IV strains but inhibited that in group I strains. The AIPs of S. aureus consist of seven to nine amino acid residues, and five of the residues form a thiolactone macrocycle by a thioester bond between a conserved cysteine and the carboxyl group of the C-terminal residue (2-4, 7-9).
Similarly, the interaction between AgrB and AgrD is group specific. Studies of AIP production from S. aureus strains containing either agrB or agrD or both genes from different groups show that group I AgrB (AgrB1) processes group I AgrD (AgrD1) and group III AgrD (AgrD3) but not group II AgrD (AgrD2) and vice versa (3). In this study, we made a series of chimeric proteins by swapping between AgrB1 and group II AgrB (AgrB2), and we used these mutant proteins to identify the AgrB segment(s) responsible for group-specific processing of AgrD in S. aureus.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. S. aureus plasmids and strains used in this study
|
Two methods were used to construct plasmids carrying chimeric agrB-his6 genes. (i) Restriction endonuclease digestion method: plasmid carrying the agrB1-his6 or agrB2-his6 gene or a derived plasmid containing a chimeric agrB-his6 gene was digested with NcoI (in the chloramphenicol acetyltransferase gene of pRN5548) and HgiAI or PstI (both sites are in the same locations of both agrB1 and agrB2 genes). The DNA fragments were purified from agarose gels. Appropriate combinations of DNA fragments were then ligated (Fig. 1). Expression plasmids pLZ2006 to pLZ2011 and pLZ2024 to pLZ2030 were made by this method (Table 2). (ii) PCR-based method: PCR products were generated with Pfu Turbo DNA polymerase (Stratagene) using oligonucleotide GJ#44 or GJ#45 (containing the NcoI site in the chloramphenicol acetyltransferase gene of pRN5548) and oligonucleotide with sequence within either the agrB1 or agrB2 gene beginning from the expected switch point as primers (oligonucleotide primers used in this study are listed in Table 3) and plasmid carrying either the agrB1-his6 or agrB2-his6 gene or a derived plasmid containing a chimeric agrB-his6 gene as templates. Oligonucleotide primers were 5' phosphorylated with T4 polynucleotide kinase before use in these PCRs. The DNA fragments were digested with NcoI and purified from agarose gels. Appropriate combinations of DNA fragments were then ligated to generate plasmids pLZ2012 to pLZ2023 (Table 2). All the constructs made were transformed into S. aureus GJ2035 (18) by the protoplast method (11). The sequences of chimeric agrB-his6 genes were confirmed by DNA sequencing.
![]() View larger version (22K): [in a new window] |
FIG. 1. Schematic presentation of plasmid carrying WT or chimeric agrB-his6. DNA fragments (A, B, C, and D) generated by restriction enzyme digestion were used to construct new chimeric agrB genes.
|
|
View this table: [in a new window] |
TABLE 2. Construction of chimeric AgrB expression plasmidsa
|
|
View this table: [in a new window] |
TABLE 3. Oligonucleotides used in this study
|
AIP activity assays. AIPs produced by induced S. aureus strains were assayed by measuring the ß-lactamase activity of the reporter strains [RN6390B(pRN6683) for group I and SA502A(pRN6683) for group II] according to the method described previously (3).
Whole-cell lysate preparation and Western blot hybridization. S. aureus cells were suspended in 1x sucrose-sodium maleate-MgCl2 (11) containing 10 µg of lysostaphin/ml and incubated for 30 min at 37°C. The protoplasts were then pelleted and lysed by addition of phosphate-buffered saline (16) supplemented with 1 mM phenylmethanesulfonyl fluoride and protease inhibitor (protease inhibitor cocktail set II; Calbiochem). The cell lysates were briefly sonicated, and the unlysed cells and cell debris were removed by centrifugation at 7,000 x g for 10 min at 4°C. Total protein concentration of the supernatant was measured with the Bio-Rad protein assay dye reagent and the optical density at 595 nm (Bio-Rad Laboratories). Whole-cell lysates in sodium dodecyl sulfate (SDS) sample buffer (16) were incubated at 70°C for 10 min before loading onto SDS-polyacrylamide gel electrophoresis gels (16). The separated proteins were electrophoretically transferred to Hybond-P polyvinylidene difluoride membranes (Amersham Pharmacia Biotech). After blocking overnight at 4°C in Tris-buffered saline (16) plus 0.05% Tween 20 and 3% bovine albumin (fraction V; Sigma), the membranes were incubated in the blocking buffer with the primary antibody (1:2,000 dilution of mouse anti-tetraHis monoclonal antibody; QIAGEN) for 1 h at room temperature. The blots were washed extensively and probed with horseradish peroxidase-conjugated goat anti-mouse secondary antibody (Amersham Pharmacia Biotech). The immunoblots were detected with an ECL Plus Western blotting detection system (Amersham Pharmacia Biotech) according to the manufacturer's instructions, followed by exposure to a HyperfilmECL film (Amersham Pharmacia Biotech).
|
|
|---|
![]() ![]() View larger version (51K): [in a new window] |
FIG. 2. The chimeric AgrBs. (A) Transmembrane topological presentation of AgrB1 (NCBI accession no. CAA36781). Identical amino acid residues between AgrB1 and AgrB2 (NCBI accession no. AAB63264) are highlighted. The switch points between AgrB1 and AgrB2 are indicated. (B) Schematic presentations of WT and chimeric AgrBs. 1, AgrB1; 2, AgrB2. Swapping points are indicated by letters. For example, 1H2P1 means that the region between the N terminus and point H is from AgrB1, the region between point H and P is from AgrB2, and the region between point P and the C terminus is from AgrB1.
|
![]() View larger version (28K): [in a new window] |
FIG. 3. Western blot analysis of whole-cell lysates from induced cells expressing WT or chimeric AgrB-His6 proteins. The same amount of total proteins was loaded in each lane. The positions of the molecular mass markers are indicated to the left by arrows. The names of AgrBs expressed are indicated at the top of each lane.
|
-helix and the extracellular loop 1 of AgrB1 are decisive in the specific processing of AgrD1.
To identify the region(s) in AgrB1 responsible for its specific processing of AgrD1, we took advantage of the existence of two restriction endonuclease cleavage sites (HgiAI and PstI) that are in the same locations in agrB1 and agrB2 genes (Fig. 2A, points H and P in AgrB). Various DNA fragments were switched between these two agrB genes, and the resulting plasmids carrying chimeric agrB genes (1H2, 1P2, 2H1, 2P1, 1H2P1, or 2H1P2) were transformed into S. aureus strain GJ4002, which contains plasmid pGJ4002 carrying the WT agrD1 gene under the control of a staphylococcal Pbla promoter (18). The ability of these chimeric AgrBs to process the AgrD1 propeptide to generate mature AIP1 was then tested by measuring the AIP1 activities of the culture supernatants from induced cells using RN6390B(pRN6683) as a reporter strain (4). These results are shown in Fig. 4. As expected, no AIP1 was produced from cells expressing AgrD1 alone or with AgrB2. Cells expressing chimeric AgrBs (1H2, 1P2, and 1H2P1) containing the AgrB1 sequence from the N terminus to point H (amino acid residues 1 to 75) processed AgrD1 and produced amounts of mature AIP1 comparable to that of the positive control, whereas cells expressing chimeric AgrBs containing the same region from AgrB2 (2H1, 2P1, and 2H1P2) did not, a finding that indicated that the N-terminal 75 amino acid residues in AgrB1 determined the group specificity.
![]() View larger version (14K): [in a new window] |
FIG. 4. AIP1 activities produced from S. aureus strains coexpressing AgrD1 and the WT and chimeric AgrBs. Culture supernatants were prepared from S. aureus cells expressing WT or chimeric AgrBs, and AgrD1 and AIP1 activities were assayed by measuring the ß-lactamase activity, using RN6390B(pRN6683) as the reporter strain as described previously (4). Values are means from three independent experiments with standard errors as indicated.
|
-helix (leucine 43 according to our proposed AgrB topology model [18]). When more of the N-terminal 75 amino acid residues from AgrB1 were added, the chimeric AgrBs 1D2 and 1E2 showed low but detectable activities in producing AIP1. Cells expressing chimeric AgrB containing the region from the N terminus to point F of AgrB1 (1F2) restored activity to approximately 85% of WT AgrB1 activity, and the addition of more AgrB1 sequence (1G2) did not further increase activity. In contrast, replacing the region between the N terminus and point F of AgrB1 with the same region of AgrB2 (2F1) eliminated its activity, whereas the presence of AgrB2 sequence down to lysine 42 in AgrB1 had no effects on its activity, as seen in cells expressing 2C1 (Fig. 4). These results suggested that the region between point C and F in AgrB1 was required for its specific processing of AgrD1, which was further confirmed by our results showing that cells expressing 2C1F2 that embedded AgrB1 sequence only between C and F in AgrB2 produced AIP1 (approximately 80% of the WT AgrB), and cells expressing mutant 1C2F1 that embedded AgrB2 sequence between C and F in AgrB1 did not. Taking together, these results suggested that the region from lysine 42 to threonine 66 of AgrB1 that formed the first transmembrane
-helix and the extracellular loop 1 (18) is essential for the group-specific interaction between AgrB1 and AgrD1. Other chimeric AgrBs constructed in this study were also tested for their abilities to process AgrD1 to generate mature AIP1. As shown in Fig. 4, only those that contained the AgrB1 C-to-F region (1F2H1P2Q1, 1F2H1, and 1P2Q1) showed AIP1 activities, whereas those that did not contain the C-to-F region (2F1Q2, 2F1H2, 2P1Q2, and 2F1H2P1Q2) did not, further confirming that the region from lysine 42 to threonine 66 of AgrB1 is required for its specific interaction with AgrD1.
The two hydrophilic segments in AgrB2 are essential for the specific processing of AgrD2. The same set of chimeric AgrBs used for the determination of AgrB1 on its specific interaction with AgrD1 were also coexpressed with WT AgrD2. The abilities of these chimeric AgrBs to generate mature AIP2 were assayed in an attempt to determine the region(s) in AgrB2 that is involved in the specific interaction with AgrD2. As shown in Fig. 5, cells with His6-tagged AgrB1 expressed together with AgrD2 did not produce AIP2 activity, and cells expressing His6-tagged AgrB2 were normally functional to produce AIP2 from AgrD2. Replacing the region between the N terminus and point C of AgrB2 by the same region of AgrB1 (1C2) had no significant effects on AgrB2 activity. Progressively adding AgrB1 sequences to AgrB2 (1D2, 1E2, 1F2, 1G2, 1H2, and 1P2) gradually reduced AgrB2 activities. When two newly constructed chimeric AgrBs (1Q2 and 1R2) were tested, the AgrB2 activities were further reduced to less than 20% of the WT AgrB2. Similarly, replacing the region between the N terminus and point C (2C1) or between the N terminus and point H (2F1) of AgrB1 with the same region of AgrB2 did not restore any AgrB2 activity. However, when more AgrB2 sequence was added to AgrB1 (2H1), low but detectable AgrB2 activity was observed. When the AgB1 regions were between the N terminus and point P and between the N terminus and point Q, these two chimeric AgrBs (2P1 and newly constructed 2Q1) had approximately 60 and 100% AgrB2 activity, respectively. These results suggested that the region between point C and point Q in AgrB2 was responsible for AgrB2 group specificity.
![]() View larger version (19K): [in a new window] |
FIG. 5. AIP2 activities produced from S. aureus strains coexpressing AgrD2 and the WT and chimeric AgrBs. AIP2 activities were assayed by measuring the ß-lactamase activity with SA502A(pRN6683) as the reporter strain as described previously (3). Values are means from three independent experiments with standard errors as indicated.
|
Chimeric AgrBs that can process both AgrD1 and AgrD2 or none. On comparison of the activities of the chimeric AgrBs we constructed and analyzed, we observed that eight chimeric AgrBs (1F2, 1G2, 1H2, 1P2, 2C1F2, 1F2H1P2Q1, 1F2H1, and 1P2Q1) (Fig. 4 and 5) were able to process both AgrD1 and AgrD2 to generate their corresponding AIPs. Among them, four chimeric AgrBs (1Q2, 1F2H1P2Q1, 1F2H1, and 1P2Q1) had higher AgrB1 activities in the processing of AgrD1 to generate mature AIP1 (Fig. 4). We also observed that four chimeric AgrBs (2F1, 2H1, 2C1F2, and 2F1Q2) had either no detectable or significant activities in the processing of both AgrD1 and AgrD2 (Fig. 4 and 5).
|
|
|---|
-helix and the extracellular loop 1) of AgrB1 was the most crucial segment in determining the specific processing of AgrD1. However, the same segment in AgrB2 was not important in its group-specific interaction with AgrD2. Instead, the two hydrophilic segments (methionine 67 to glycine 75 and alanine 126 to lysine 141) in AgrB2 were required for its specific processing of AgrD2. The AgrD1 and AgrD2 sequences and their corresponding AIPs are different. (An alignment of these AgrDs is shown below [AgrD1, NCBI accession no. CAA36782; AgrD2, NCBI accession no. AAB63265]. The AIP sequences are shown in bold.)
AgrD1, MNTLFNLFFDFITGILKNIGNIAAYSTCDFIMDEVEVPKELTQLHE
AgrD2, MNTLVNMFFDFIIKLAKAIGIVGGVNACSSLFDEPKVPAELTNLYDK
The processing of AgrD to generate mature AIP is a complicated process involving proteolytic cleavage at two sites, the formation of a thioester bond between the sulfhydryl group of the cysteine residues and the carboxyl group of the C-terminal amino acid residue of the AIP sequence and the secretion of the mature AIP. AgrB is a membrane protein with six transmembrane segments (18). It has been proposed that the four
-helices form a channel and the two hydrophilic segments are located inside (18). So, it is possible that the interactions between AgrB and AgrD occur in the intramembranous and/or juxtamembranous compartment. Although the segments responsible for the group-specific interaction in AgrB1 and AgrB2 were found to be different, the folding of AgrB may bring together the transmembrane segments; thus, the first transmembrane
-helix and the two hydrophilic segments may form a group-specific interactive domain.
AgrB has been proposed both as an endopeptidase that is involved in proteolytic cleavages of AgrD and as an oligopeptide transporter that secretes the mature AIP. The proteolytic reactions in AgrBs are likely to be conserved, whereas processes such as substrate binding and mature AIP secretion could be group specific. Recently, our laboratory has identified two amino acid residues (histidine 77 and cysteine 83) in both S. aureus AgrB1 (L. Zhang, R. Qiu, and G. Ji, unpublished data) and Staphylococcus intermedius AgrB (W. Pei and G. Ji, unpublished data) that are required for its activity. Most possibly these two amino acid residues form a catalytic center of a putative endopeptidase. These two amino acids are at the same positions and conserved among all AgrBs identified so far, and they are located juxtapositionally on the inner surface of the cytoplasmic membrane according to the AgrB1 topological model (Fig. 2A) (18). It is likely the catalytic activities are conserved among these AgrBs. The true nature of this putative endopeptidase is unclear. It is possible AgrB is a cysteine endopeptidase, since cysteine and histidine are the two most common conserved residues that form the catalytic centers of cysteine peptidases (15), though AgrBs have no sequence homologies with other cysteine peptidase and mutations in other conserved residues among AgrBs that have catalytic potential found in other types of proteases did not totally eliminate its activity (W. Pei, R. Qiu, L. Zhang, and G. Ji, unpublished data). Furthermore, when all the chimeric AgrB mutants were tested, eight were able to process AgrD propeptide from both groups to produce significant levels of AIP activities. Of note, the two hydrophilic segments were relatively conserved in both AgrBs, with three and four amino acid differences, respectively. It is interesting that chimeric AgrB 1F2H1P2Q1, which consisted of AgrB1 sequence with only seven amino acids from AgrB2, was able to process both AgrDs to produce comparable or even higher AIP activities than the WT AgrB. These results suggested that while the interaction between AgrB and AgrD is group specific, the mechanisms of the AgrD processing to generate AIP by the AgrB protein are the same or similar.
This work was supported by National Institutes of Health grant RO1AI46445 and a Uniformed Services University of Health Sciences grant to G.J.
Present address: Division of Pediatric Oncology, The Johns Hopkins University, Baltimore, MD 21231. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»